The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment - Takeaways - MDSpire

The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment

  • By

  • Xingxing Tao

  • Yingjie Liu

  • Peishan Yu

  • Wenjiang Wu

  • Yanli Fu

  • Ping Lan

  • Shengzhu Jin

  • June 19, 2026

  • 0 min

Share

  • 1

    Protein lactylation, driven by lactate, links metabolic state to gene regulation in the tumor microenvironment.

  • 2

    Lactylation promotes tumor malignancy by reshaping chromatin accessibility and enhancing oncogenic signaling pathways.

  • 3

    Lactylation reprograms immune cells, driving macrophages to an M2-like phenotype and inducing dysfunction in CD8+ T cells.

  • 4

    The tumor microenvironment's acidic conditions facilitate lactate accumulation, influencing both tumor progression and immune evasion.

  • 5

    Targeting lactylation may offer therapeutic strategies to reverse immunosuppression and improve cancer treatment outcomes.

Original Source(s)

Related Content